nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketobemidone—CYP3A4—type 2 diabetes mellitus	0.176	1	CbGaD
Ketobemidone—UGT1A9—Nateglinide—type 2 diabetes mellitus	0.0675	0.0929	CbGbCtD
Ketobemidone—PTGS1—Pioglitazone—type 2 diabetes mellitus	0.037	0.0509	CbGbCtD
Ketobemidone—PTGS1—Chlorpropamide—type 2 diabetes mellitus	0.037	0.0509	CbGbCtD
Ketobemidone—PTGS1—Rosiglitazone—type 2 diabetes mellitus	0.0341	0.047	CbGbCtD
Ketobemidone—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0295	0.0406	CbGbCtD
Ketobemidone—PTGS1—Nateglinide—type 2 diabetes mellitus	0.028	0.0386	CbGbCtD
Ketobemidone—PTGS1—Irbesartan—type 2 diabetes mellitus	0.0269	0.037	CbGbCtD
Ketobemidone—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0236	0.0325	CbGbCtD
Ketobemidone—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0214	0.0294	CbGbCtD
Ketobemidone—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0211	0.029	CbGbCtD
Ketobemidone—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0206	0.0283	CbGbCtD
Ketobemidone—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0197	0.0271	CbGbCtD
Ketobemidone—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.019	0.0262	CbGbCtD
Ketobemidone—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0188	0.0259	CbGbCtD
Ketobemidone—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0179	0.0246	CbGbCtD
Ketobemidone—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0179	0.0246	CbGbCtD
Ketobemidone—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0175	0.0241	CbGbCtD
Ketobemidone—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0165	0.0227	CbGbCtD
Ketobemidone—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.016	0.022	CbGbCtD
Ketobemidone—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0155	0.0213	CbGbCtD
Ketobemidone—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.0149	0.0205	CbGbCtD
Ketobemidone—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.0149	0.0205	CbGbCtD
Ketobemidone—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0137	0.0189	CbGbCtD
Ketobemidone—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0134	0.0185	CbGbCtD
Ketobemidone—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0133	0.0183	CbGbCtD
Ketobemidone—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0121	0.0167	CbGbCtD
Ketobemidone—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.012	0.0165	CbGbCtD
Ketobemidone—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.0113	0.0155	CbGbCtD
Ketobemidone—CYP3A4—Glipizide—type 2 diabetes mellitus	0.011	0.0151	CbGbCtD
Ketobemidone—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.0108	0.0149	CbGbCtD
Ketobemidone—CYP2C8—Losartan—type 2 diabetes mellitus	0.01	0.0137	CbGbCtD
Ketobemidone—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00957	0.0132	CbGbCtD
Ketobemidone—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00917	0.0126	CbGbCtD
Ketobemidone—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00866	0.0119	CbGbCtD
Ketobemidone—CYP2C19—Losartan—type 2 diabetes mellitus	0.00839	0.0115	CbGbCtD
Ketobemidone—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00762	0.0105	CbGbCtD
Ketobemidone—CYP2C9—Losartan—type 2 diabetes mellitus	0.00697	0.00959	CbGbCtD
Ketobemidone—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00656	0.00902	CbGbCtD
Ketobemidone—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00629	0.00865	CbGbCtD
Ketobemidone—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00629	0.00865	CbGbCtD
Ketobemidone—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00595	0.00818	CbGbCtD
Ketobemidone—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00443	0.0061	CbGbCtD
Ketobemidone—CYP3A4—Losartan—type 2 diabetes mellitus	0.00405	0.00558	CbGbCtD
Ketobemidone—Pethidine—CYP3A4—type 2 diabetes mellitus	0.000199	0.534	CrCbGaD
Ketobemidone—Pethidine—ALB—type 2 diabetes mellitus	0.000174	0.466	CrCbGaD
Ketobemidone—CYP2B6—Metabolism—PPARGC1A—type 2 diabetes mellitus	6.87e-06	7.15e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GNB3—type 2 diabetes mellitus	6.87e-06	7.15e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CYP3A4—type 2 diabetes mellitus	6.86e-06	7.14e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.85e-06	7.13e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—HMOX1—type 2 diabetes mellitus	6.84e-06	7.11e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.83e-06	7.1e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	6.82e-06	7.09e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	6.81e-06	7.09e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	6.81e-06	7.09e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—APOA1—type 2 diabetes mellitus	6.79e-06	7.07e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	6.75e-06	7.03e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GCG—type 2 diabetes mellitus	6.74e-06	7.02e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—SLC2A4—type 2 diabetes mellitus	6.74e-06	7.02e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CAT—type 2 diabetes mellitus	6.74e-06	7.02e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.74e-06	7.01e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.73e-06	7e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.7e-06	6.97e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.66e-06	6.93e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	6.61e-06	6.88e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—ALB—type 2 diabetes mellitus	6.6e-06	6.87e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—RELA—type 2 diabetes mellitus	6.56e-06	6.82e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—APOB—type 2 diabetes mellitus	6.55e-06	6.81e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	6.5e-06	6.76e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	6.48e-06	6.74e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.4e-06	6.66e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GSTM1—type 2 diabetes mellitus	6.37e-06	6.63e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	6.35e-06	6.61e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	6.35e-06	6.61e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	6.33e-06	6.59e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	6.33e-06	6.59e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	6.33e-06	6.59e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PIK3R1—type 2 diabetes mellitus	6.31e-06	6.57e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—NOS3—type 2 diabetes mellitus	6.31e-06	6.57e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	6.28e-06	6.53e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	6.28e-06	6.53e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—LPL—type 2 diabetes mellitus	6.25e-06	6.51e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	6.21e-06	6.47e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	6.16e-06	6.41e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.15e-06	6.4e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	6.12e-06	6.37e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ADCY5—type 2 diabetes mellitus	6.12e-06	6.37e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.11e-06	6.35e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.11e-06	6.35e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—GPX1—type 2 diabetes mellitus	6.1e-06	6.35e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	6.09e-06	6.34e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	6.07e-06	6.32e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	6.07e-06	6.31e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	6.03e-06	6.27e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	6.02e-06	6.27e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	6.02e-06	6.27e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PPARG—type 2 diabetes mellitus	5.98e-06	6.23e-05	CbGpPWpGaD
Ketobemidone—OPRD1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.97e-06	6.21e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CD36—type 2 diabetes mellitus	5.94e-06	6.18e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.91e-06	6.15e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—INS—type 2 diabetes mellitus	5.89e-06	6.12e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.87e-06	6.11e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—INS—type 2 diabetes mellitus	5.87e-06	6.11e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPP2CA—type 2 diabetes mellitus	5.87e-06	6.1e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.86e-06	6.1e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.86e-06	6.1e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.86e-06	6.1e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.86e-06	6.1e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.81e-06	6.05e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	5.81e-06	6.05e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	5.79e-06	6.03e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	5.79e-06	6.03e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	5.79e-06	6.02e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—PTGS2—type 2 diabetes mellitus	5.77e-06	6.01e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.75e-06	5.98e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	5.73e-06	5.96e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	5.73e-06	5.96e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	5.71e-06	5.94e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	5.69e-06	5.92e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	5.69e-06	5.92e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	5.66e-06	5.89e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—MTHFR—type 2 diabetes mellitus	5.63e-06	5.86e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	5.62e-06	5.85e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.59e-06	5.81e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	5.58e-06	5.81e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	5.56e-06	5.78e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	5.54e-06	5.77e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.53e-06	5.75e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARA—type 2 diabetes mellitus	5.52e-06	5.75e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	5.49e-06	5.71e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	5.49e-06	5.71e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	5.42e-06	5.64e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.41e-06	5.63e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	5.39e-06	5.61e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—ALB—type 2 diabetes mellitus	5.38e-06	5.6e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AGT—type 2 diabetes mellitus	5.35e-06	5.57e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	5.29e-06	5.51e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—CALM1—type 2 diabetes mellitus	5.26e-06	5.47e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—APOE—type 2 diabetes mellitus	5.24e-06	5.45e-05	CbGpPWpGaD
Ketobemidone—OPRK1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.23e-06	5.45e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	5.22e-06	5.44e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	5.19e-06	5.4e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.19e-06	5.4e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.18e-06	5.4e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	5.18e-06	5.39e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—APOA1—type 2 diabetes mellitus	5.18e-06	5.39e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	5.17e-06	5.38e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	5.16e-06	5.37e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.16e-06	5.37e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.16e-06	5.37e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—SRC—type 2 diabetes mellitus	5.15e-06	5.36e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—IL6—type 2 diabetes mellitus	5.15e-06	5.36e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PIK3R1—type 2 diabetes mellitus	5.15e-06	5.35e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—NOS3—type 2 diabetes mellitus	5.15e-06	5.35e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	5.1e-06	5.3e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	5.03e-06	5.23e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	5.02e-06	5.22e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	4.97e-06	5.17e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	4.95e-06	5.15e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.9e-06	5.1e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.88e-06	5.07e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	4.86e-06	5.06e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.85e-06	5.04e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	4.81e-06	5.01e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.78e-06	4.97e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.78e-06	4.97e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	4.77e-06	4.96e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.75e-06	4.95e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	4.73e-06	4.92e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.73e-06	4.92e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	4.72e-06	4.92e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	4.71e-06	4.9e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—PTGS2—type 2 diabetes mellitus	4.71e-06	4.9e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.68e-06	4.88e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	4.68e-06	4.87e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.66e-06	4.84e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.66e-06	4.84e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.66e-06	4.84e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	4.65e-06	4.84e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.63e-06	4.81e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	4.62e-06	4.81e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	4.61e-06	4.8e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.61e-06	4.79e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PPARG—type 2 diabetes mellitus	4.56e-06	4.75e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	4.54e-06	4.73e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	4.53e-06	4.71e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.52e-06	4.7e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.52e-06	4.7e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	4.51e-06	4.69e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	4.49e-06	4.67e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	4.49e-06	4.67e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—INS—type 2 diabetes mellitus	4.48e-06	4.66e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	4.45e-06	4.63e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	4.44e-06	4.62e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	4.43e-06	4.61e-05	CbGpPWpGaD
Ketobemidone—OPRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	4.42e-06	4.6e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.4e-06	4.58e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	4.39e-06	4.57e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	4.39e-06	4.56e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.38e-06	4.56e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.35e-06	4.53e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	4.31e-06	4.48e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	4.25e-06	4.43e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	4.22e-06	4.39e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	4.2e-06	4.37e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	4.18e-06	4.35e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	4.18e-06	4.35e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	4.18e-06	4.35e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	4.17e-06	4.34e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.14e-06	4.31e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—ALB—type 2 diabetes mellitus	4.1e-06	4.27e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	4.1e-06	4.27e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.1e-06	4.26e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	4.09e-06	4.26e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	4.06e-06	4.23e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	4.04e-06	4.21e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	4.04e-06	4.21e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.04e-06	4.2e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.02e-06	4.18e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.97e-06	4.14e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	3.97e-06	4.14e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	3.96e-06	4.12e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.96e-06	4.12e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.93e-06	4.09e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—NOS3—type 2 diabetes mellitus	3.93e-06	4.09e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	3.91e-06	4.07e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	3.88e-06	4.04e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	3.86e-06	4.02e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.82e-06	3.97e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	3.82e-06	3.97e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	3.81e-06	3.96e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	3.79e-06	3.94e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.78e-06	3.93e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.78e-06	3.93e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	3.72e-06	3.87e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	3.69e-06	3.83e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	3.62e-06	3.77e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.62e-06	3.77e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.62e-06	3.77e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	3.61e-06	3.76e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—PTGS2—type 2 diabetes mellitus	3.59e-06	3.74e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	3.57e-06	3.71e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	3.47e-06	3.62e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.47e-06	3.61e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	3.45e-06	3.59e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.41e-06	3.55e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	3.38e-06	3.52e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.35e-06	3.48e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	3.32e-06	3.46e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	3.32e-06	3.46e-05	CbGpPWpGaD
Ketobemidone—OPRD1—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.2e-06	3.33e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	3.15e-06	3.27e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	3.12e-06	3.25e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.12e-06	3.25e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	3.11e-06	3.23e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	3.1e-06	3.23e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	3.08e-06	3.21e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	3.06e-06	3.19e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—IL6—type 2 diabetes mellitus	3.04e-06	3.17e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	3.04e-06	3.16e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.98e-06	3.1e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.97e-06	3.09e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.97e-06	3.09e-05	CbGpPWpGaD
Ketobemidone—UGT1A9—Metabolism—AKT1—type 2 diabetes mellitus	2.9e-06	3.02e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.89e-06	3.01e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.84e-06	2.96e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	2.83e-06	2.94e-05	CbGpPWpGaD
Ketobemidone—OPRK1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.81e-06	2.92e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.78e-06	2.89e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.77e-06	2.88e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	2.71e-06	2.82e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	2.71e-06	2.81e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	2.71e-06	2.81e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.7e-06	2.81e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.67e-06	2.77e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.57e-06	2.68e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.56e-06	2.66e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.51e-06	2.61e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	2.47e-06	2.57e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.43e-06	2.53e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.39e-06	2.49e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.38e-06	2.48e-05	CbGpPWpGaD
Ketobemidone—OPRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.37e-06	2.47e-05	CbGpPWpGaD
Ketobemidone—PTGS1—Metabolism—AKT1—type 2 diabetes mellitus	2.37e-06	2.46e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.35e-06	2.45e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	2.07e-06	2.16e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	2.03e-06	2.12e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.87e-06	1.94e-05	CbGpPWpGaD
Ketobemidone—CYP2B6—Metabolism—AKT1—type 2 diabetes mellitus	1.8e-06	1.88e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.78e-06	1.86e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.78e-06	1.86e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.63e-06	1.7e-05	CbGpPWpGaD
Ketobemidone—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.53e-06	1.59e-05	CbGpPWpGaD
Ketobemidone—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	1.36e-06	1.42e-05	CbGpPWpGaD
Ketobemidone—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	1.24e-06	1.29e-05	CbGpPWpGaD
Ketobemidone—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	8.2e-07	8.53e-06	CbGpPWpGaD
